Arab World vs France: Access to anti-retroviral drugs, male
Arab World
49.3%
in 2024
France
89.0%
in 2022
Arab World rank
16th
France rank
17th
Access to anti-retroviral drugs, male over time
- Arab World
- France
How they compare
France currently reports 89.0% against 49.3% in Arab World, a difference of 39.7%.
That makes France's figure about 1.8 times Arab World's.
Across all 23 years both countries report, France has been ahead every year.
Arab World ranks 16th and France ranks 17th of 19 groups.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 79.8% | 72.9% | France |
| 2010s | 24.3% | 86.9% | 62.6% | France |
| 2020s | 41.9% | 88.7% | 46.8% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Arab World or France?
- France, at 89.0% against 49.3% in Arab World as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Arab World and France?
- 39.7%, with France ahead.
- How many years of comparable data are there for Arab World and France?
- 23 years are reported by both, from 2000 to 2022.
- How do Arab World and France rank globally for access to anti-retroviral drugs, male?
- Arab World ranks 16th and France ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.